{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:24:15Z","timestamp":1774931055253,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":22,"publisher":"Springer US","isbn-type":[{"value":"9781071618912","type":"print"},{"value":"9781071618929","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1892-9_14","type":"book-chapter","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T17:06:35Z","timestamp":1639674395000},"page":"283-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of Optical In Vivo Imaging to Monitor and Optimize Delivery of Novel Plasmid-Launched Live-Attenuated Vaccines"],"prefix":"10.1007","author":[{"given":"Sapna","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Dallmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"issue":"1","key":"14_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/imr.12099","volume":"255","author":"B Pulendran","year":"2013","unstructured":"Pulendran B et al (2013) Immunity to viruses: learning from successful human vaccines. Immunol Rev 255(1):243\u2013255","journal-title":"Immunol Rev"},{"issue":"1","key":"14_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nrmicro2240","volume":"8","author":"SJ Draper","year":"2010","unstructured":"Draper SJ, Heeney JL (2010) Viruses as vaccine vectors for infectious diseases and cancer. Nat Rev Microbiol 8(1):62\u201373","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"14_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1080\/14760584.2016.1175943","volume":"15","author":"P Pushko","year":"2016","unstructured":"Pushko P et al (2016) DNA-launched live-attenuated vaccines for biodefense applications. Expert Rev Vaccines 15(9):1223\u20131234","journal-title":"Expert Rev Vaccines"},{"issue":"44","key":"14_CR4","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1016\/j.vaccine.2015.06.110","volume":"33","author":"F Aubrit","year":"2015","unstructured":"Aubrit F et al (2015) Cell substrates for the production of viral vaccines. Vaccine 33(44):5905\u20135912","journal-title":"Vaccine"},{"issue":"9","key":"14_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/biot.201400387","volume":"10","author":"AF Rodrigues","year":"2015","unstructured":"Rodrigues AF et al (2015) Viral vaccines and their manufacturing cell substrates: new trends and designs in modern vaccinology. Biotechnol J 10(9):1329\u20131344","journal-title":"Biotechnol J"},{"issue":"25","key":"14_CR6","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1016\/j.vaccine.2019.04.072","volume":"37","author":"I Tretyakova","year":"2019","unstructured":"Tretyakova I et al (2019) Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome. Vaccine 37(25):3317\u20133325","journal-title":"Vaccine"},{"issue":"Pt 4","key":"14_CR7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1099\/jgv.0.000026","volume":"96","author":"X Jiang","year":"2015","unstructured":"Jiang X et al (2015) Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone. J Gen Virol 96(Pt 4):804\u2013814","journal-title":"J Gen Virol"},{"issue":"1","key":"14_CR8","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1080\/22221751.2019.1694394","volume":"8","author":"DB Kum","year":"2019","unstructured":"Kum DB et al (2019) Limited evolution of the yellow fever virus 17d in a mouse infection model. Emerg Microbes Infect 8(1):1734\u20131746","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"14_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nri1310","volume":"4","author":"TS Kupper","year":"2004","unstructured":"Kupper TS, Fuhlbrigge RC (2004) Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 4(3):211\u2013222","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"14_CR10","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1073\/pnas.0807126106","volume":"106","author":"K Nagao","year":"2009","unstructured":"Nagao K et al (2009) Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci U S A 106(9):3312\u20133317","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"14_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001993","volume":"3","author":"AH Roukens","year":"2008","unstructured":"Roukens AH et al (2008) Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. PLoS One 3(4):e1993","journal-title":"PLoS One"},{"issue":"48","key":"14_CR12","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1016\/j.vaccine.2011.09.077","volume":"29","author":"F Young","year":"2011","unstructured":"Young F, Marra F (2011) A systematic review of intradermal influenza vaccines. Vaccine 29(48):8788\u20138801","journal-title":"Vaccine"},{"issue":"11","key":"14_CR13","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1089\/aid.2015.0101","volume":"31","author":"DS Rosa","year":"2015","unstructured":"Rosa DS et al (2015) Multiple approaches for increasing the immunogenicity of an epitope-based anti-HIV vaccine. AIDS Res Hum Retrovir 31(11):1077\u20131088","journal-title":"AIDS Res Hum Retrovir"},{"issue":"3","key":"14_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.micinf.2007.11.009","volume":"10","author":"L Zhang","year":"2008","unstructured":"Zhang L et al (2008) T cell epitope-based peptide-DNA dual vaccine induces protective immunity against Schistosoma japonicum infection in C57BL\/6J mice. Microbes Infect 10(3):251\u2013259","journal-title":"Microbes Infect"},{"issue":"6982","key":"14_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature02463","volume":"428","author":"ZY Yang","year":"2004","unstructured":"Yang ZY et al (2004) A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428(6982):561\u2013564","journal-title":"Nature"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3389\/fimmu.2018.01568","volume":"9","author":"LYY Lee","year":"2018","unstructured":"Lee LYY, Izzard L, Hurt AC (2018) A review of DNA vaccines against influenza. Front Immunol 9:1568","journal-title":"Front Immunol"},{"issue":"3","key":"14_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","volume":"15","author":"L Li","year":"2016","unstructured":"Li L, Petrovsky N (2016) Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines 15(3):313\u2013329","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"14_CR18","first-page":"697","volume":"34","author":"Y Zhu","year":"2003","unstructured":"Zhu Y et al (2003) Protective immunity induced with 23 kDa membrane protein dna vaccine of Schistosoma japonicum Chinese strain in infected C57BL\/6 mice. Southeast Asian J Trop Med Public Health 34(4):697\u2013701","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"1","key":"14_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/21505594.2017.1371897","volume":"9","author":"P Avci","year":"2018","unstructured":"Avci P et al (2018) In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging. Virulence 9(1):28\u201363","journal-title":"Virulence"},{"issue":"9","key":"14_CR20","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1080\/21645515.2020.1765621","volume":"16","author":"S Sharma","year":"2020","unstructured":"Sharma S et al (2020) Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine. Hum Vaccin Immunother 16(9):2196\u20132203","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"14_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02494-19","volume":"11","author":"N Mishra","year":"2020","unstructured":"Mishra N et al (2020) A Chimeric Japanese encephalitis vaccine protects against lethal yellow fever virus infection without inducing neutralizing antibodies. mBio 11(2):e02494-19","journal-title":"mBio"},{"issue":"1","key":"14_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1080\/22221751.2020.1730709","volume":"9","author":"DB Kum","year":"2020","unstructured":"Kum DB et al (2020) A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice. Emerg Microbes Infect 9(1):520\u2013533","journal-title":"Emerg Microbes Infect"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1892-9_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T05:25:48Z","timestamp":1641014748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1892-9_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"ISBN":["9781071618912","9781071618929"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1892-9_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"17 December 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}